These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
578 related articles for article (PubMed ID: 30803129)
1. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer. Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells. Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678 [TBL] [Abstract][Full Text] [Related]
3. The long non-coding RNA NEAT1 interacted with miR-101 modulates breast cancer growth by targeting EZH2. Qian K; Liu G; Tang Z; Hu Y; Fang Y; Chen Z; Xu X Arch Biochem Biophys; 2017 Feb; 615():1-9. PubMed ID: 28034643 [TBL] [Abstract][Full Text] [Related]
4. NEAT1 contributes to breast cancer progression through modulating miR-448 and ZEB1. Jiang X; Zhou Y; Sun AJ; Xue JL J Cell Physiol; 2018 Nov; 233(11):8558-8566. PubMed ID: 29323713 [TBL] [Abstract][Full Text] [Related]
5. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer. Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977 [TBL] [Abstract][Full Text] [Related]
6. The expression profiling of circulating miR-204, miR-182, and lncRNA H19 as novel potential biomarkers for the progression of peptic ulcer to gastric cancer. Mohamed WA; Schaalan MF; Ramadan B J Cell Biochem; 2019 Aug; 120(8):13464-13477. PubMed ID: 30945348 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152. Li Z; Li Y; Li Y; Ren K; Li X; Han X; Wang J J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28544374 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines. Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600 [TBL] [Abstract][Full Text] [Related]
9. Huaier Extract Inhibits Breast Cancer Progression Through a LncRNA-H19/MiR-675-5p Pathway. Wang J; Wang X; Chen T; Jiang L; Yang Q Cell Physiol Biochem; 2017; 44(2):581-593. PubMed ID: 29145193 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer. Yang J; Wu W; Wu M; Ding J In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061 [TBL] [Abstract][Full Text] [Related]
11. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients. Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342 [TBL] [Abstract][Full Text] [Related]
12. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer. Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400 [TBL] [Abstract][Full Text] [Related]
13. The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer. Li X; Wang S; Li Z; Long X; Guo Z; Zhang G; Zu J; Chen Y; Wen L Int J Biol Macromol; 2017 Dec; 105(Pt 1):346-353. PubMed ID: 28720546 [TBL] [Abstract][Full Text] [Related]
14. Identification of lncRNA NEAT1/miR-21/RRM2 axis as a novel biomarker in breast cancer. Quan D; Chen K; Zhang J; Guan Y; Yang D; Wu H; Wu S; Lv L J Cell Physiol; 2020 Apr; 235(4):3372-3381. PubMed ID: 31621912 [TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression. Zhang H; Cai Y; Zheng L; Zhang Z; Lin X; Jiang N J Cell Physiol; 2018 Oct; 233(10):6638-6648. PubMed ID: 29319165 [TBL] [Abstract][Full Text] [Related]
17. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects. Han L; Ma P; Liu SM; Zhou X Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314 [TBL] [Abstract][Full Text] [Related]
18. The functional pathway analysis and clinical significance of miR-20a and its related lncRNAs in breast cancer. Zhao L; Zhao Y; He Y; Li Q; Mao Y Cell Signal; 2018 Nov; 51():152-165. PubMed ID: 30092355 [TBL] [Abstract][Full Text] [Related]
19. LncRNA H19/microRNA-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt/mTOR signalling. Liu Y; Xu L; Lu B; Zhao M; Li L; Sun W; Qiu Z; Zhang B Mol Immunol; 2019 Dec; 116():18-28. PubMed ID: 31574452 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p. Kong Q; Qiu M Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]